Literature DB >> 33962146

A meta-analysis on potential modifiers of LITT efficacy for mesial temporal lobe epilepsy: Seizure-freedom seems to fade with time.

Alexandros G Brotis1, Theofanis Giannis2, Thanos Paschalis2, Eftychia Kapsalaki3, Efthymios Dardiotis4, Konstantinos N Fountas2.   

Abstract

BACKGROUND: The efficacy of laser interstitial thermal therapy (LITT) in mesial temporal lobe epilepsy (MTLE) has not been clearly established yet.
OBJECTIVE: We conducted a meta-analysis to estimate the efficacy of LITT for TLE (Q1). We also examined the effect of the patient's age (Q2), the total ablation volume (TAV) (Q3), the strength of the MRI unit (Q4), the type of the utilized stereotactic platform (Q5), and the follow up period (Q6) on the patient's outcome.
METHODS: Fixed- and random-effects model meta-analysis was conducted to assess the proportion estimate for each parameter individually. Kaplan-Meier survival-analysis was performed on the available individual patient time-to-first seizure data.
RESULTS: Sixteen studies with 575 patients fulfilled our eligibility criteria. The efficacy of LITT was 0.547 (95%CI: 0.506-0.588). Our statistical analysis had robust results after stratification according to the study population (Q2; p = 0.3418), and the type of the utilized stereotactic platform (Q5; p = 0.286), whereas the role of the TAV (Q3; p = 0.058) and strength of the magnetic field (Q4; p = 0.062) in seizure control remained unclear. The median seizure-free period (Q6) was 0.643 (0.569-0.726) and 0.467 (0.385-0.566) for the one- and the two-year follow up.
CONCLUSIONS: LITT seems to offer a viable alternative to resective surgery, with a moderate efficacy and enduring results. Higher ablation volumes may be associated with improved seizure control, although our current study provided no statistically significant data. More high-quality studies are required to highlight the role of LITT in epilepsy surgery, particularly in the pediatric population.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Efficacy; Intractable epilepsy; Laser interstitial thermal therapy; Medically-refractory epilepsy

Year:  2021        PMID: 33962146     DOI: 10.1016/j.clineuro.2021.106644

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy.

Authors:  Lara Jehi; Nathalie Jette; Churl-Su Kwon; Colin B Josephson; Jorge G Burneo; Fernando Cendes; Michael R Sperling; Sallie Baxendale; Robyn M Busch; Chahnez Charfi Triki; J Helen Cross; Dana Ekstein; Dario J Englot; Guoming Luan; Andre Palmini; Loreto Rios; Xiongfei Wang; Karl Roessler; Bertil Rydenhag; Georgia Ramantani; Stephan Schuele; Jo M Wilmshurst; Sarah Wilson; Samuel Wiebe
Journal:  Epilepsia       Date:  2022-07-17       Impact factor: 6.740

2.  Seizure Outcomes and Reoperation in Surgical Rasmussen Encephalitis Patients.

Authors:  Swetha J Sundar; Elaine Lu; Eric S Schmidt; Efstathios D Kondylis; Deborah Vegh; Matthew J Poturalski; Juan C Bulacio; Lara Jehi; Ajay Gupta; Elaine Wyllie; William E Bingaman
Journal:  Neurosurgery       Date:  2022-05-13       Impact factor: 5.315

3.  Temporal lobe epilepsy surgery: Piriform cortex resection impacts seizure control in the long-term.

Authors:  Valeri Borger; Motaz Hamed; Majd Bahna; Áttila Rácz; Inja Ilic; Anna-Laura Potthoff; Tobias Baumgartner; Theodor Rüber; Albert Becker; Alexander Radbruch; Florian Mormann; Rainer Surges; Hartmut Vatter; Matthias Schneider
Journal:  Ann Clin Transl Neurol       Date:  2022-07-01       Impact factor: 5.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.